Targeting CRTC2 reverses STK11 mutant NSCLC tumor resistance to immunotherapy
靶向 CRTC2 可逆转 STK11 突变型非小细胞肺癌肿瘤对免疫疗法的耐药性
期刊:Proceedings of the National Academy of Sciences of the United States of America
影响因子:9.1
doi:10.1073/pnas.2508762123
Robay, Dimitri; Ackermann, Ole; Laborde, Laurent; Shi, Xingyi; Oreglia, Federico; Stump, Ramona; Ciaghi, Sabina; Galli, Giorgio G; Holzer, Laura; Villemin, Lorraine; Wagner, Joel; Wu, Jincheng; Lee, Lang Ho; Bossen, Claudia; Mourikis, Thanos P; Gabriel, Millicent; Ruddy, David; Yu, Haiyan; Johannessen, Cory; Ferretti, Stephane; Costa, Carlotta
免疫/内分泌
细胞生物学
CRTC2
STK11
肺癌
肿瘤
肿瘤免疫
